Because initial findings suggest the COVID-19 omicron variant may be less lethal than anticipated, the market is expected to maintain its long-term uptrend. So, we think it could be wise to bet on cheap yet quality stocks Teva Pharmaceutical (TEVA), Himax Technologies (HIMX), YPF Sociedad Anónima (YPF), and LexinFintech Holdings (LX). They are each currently trading at affordable prices. So read on for a closer examination of these names.
The newly identified COVID-19 omicron variant has dampened investor sentiment, with global markets showing weakness. However, with initial findings suggesting the effects of the variant may be mild, experts believe it will not halt the U.S. economic recovery.
